539 related articles for article (PubMed ID: 11238629)
1. Inhibition of the MEK/ERK signaling pathway blocks a subset of B cell responses to antigen.
Richards JD; Davé SH; Chou CH; Mamchak AA; DeFranco AL
J Immunol; 2001 Mar; 166(6):3855-64. PubMed ID: 11238629
[TBL] [Abstract][Full Text] [Related]
2. Differential roles for extracellularly regulated kinase-mitogen-activated protein kinase in B cell antigen receptor-induced apoptosis and CD40-mediated rescue of WEHI-231 immature B cells.
Gauld SB; Blair D; Moss CA; Reid SD; Harnett MM
J Immunol; 2002 Apr; 168(8):3855-64. PubMed ID: 11937539
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
Fukazawa H; Noguchi K; Murakami Y; Uehara Y
Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
[TBL] [Abstract][Full Text] [Related]
4. Requirement for a hsp90 chaperone-dependent MEK1/2-ERK pathway for B cell antigen receptor-induced cyclin D2 expression in mature B lymphocytes.
Piatelli MJ; Doughty C; Chiles TC
J Biol Chem; 2002 Apr; 277(14):12144-50. PubMed ID: 11823472
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase-dependent mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 and NF-kappa B signaling pathways are required for B cell antigen receptor-mediated cyclin D2 induction in mature B cells.
Piatelli MJ; Wardle C; Blois J; Doughty C; Schram BR; Rothstein TL; Chiles TC
J Immunol; 2004 Mar; 172(5):2753-62. PubMed ID: 14978074
[TBL] [Abstract][Full Text] [Related]
6. Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation.
Wu HJ; Venkataraman C; Estus S; Dong C; Davis RJ; Flavell RA; Bondada S
J Immunol; 2001 Aug; 167(3):1263-73. PubMed ID: 11466342
[TBL] [Abstract][Full Text] [Related]
7. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
8. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
[TBL] [Abstract][Full Text] [Related]
9. Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
Wiesenauer CA; Yip-Schneider MT; Wang Y; Schmidt CM
J Am Coll Surg; 2004 Mar; 198(3):410-21. PubMed ID: 14992744
[TBL] [Abstract][Full Text] [Related]
10. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
Miranda MB; McGuire TF; Johnson DE
Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
12. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
Yu TK; Caudell EG; Smid C; Grimm EA
J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
[TBL] [Abstract][Full Text] [Related]
13. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
Craxton A; Draves KE; Gruppi A; Clark EA
J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells.
Li YY; Baccam M; Waters SB; Pessin JE; Bishop GA; Koretzky GA
J Immunol; 1996 Aug; 157(4):1440-7. PubMed ID: 8759724
[TBL] [Abstract][Full Text] [Related]
15. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway.
Purkerson JM; Parker DC
J Immunol; 1998 Mar; 160(5):2121-9. PubMed ID: 9498749
[TBL] [Abstract][Full Text] [Related]
16. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
Swart JM; Bergeron DM; Chiles TC
J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
[TBL] [Abstract][Full Text] [Related]
17. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor up-regulation via EGR-1 in endothelial cells.
Mechtcheriakova D; Schabbauer G; Lucerna M; Clauss M; De Martin R ; Binder BR; Hofer E
FASEB J; 2001 Jan; 15(1):230-242. PubMed ID: 11149911
[TBL] [Abstract][Full Text] [Related]
18. BCR mediated signal transduction in immature and mature B cells.
Koncz G; Bodor C; Kövesdi D; Gáti R; Sármay G
Immunol Lett; 2002 Jun; 82(1-2):41-9. PubMed ID: 12008033
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of the MEK/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.
Zhang J; Lodish HF
Blood; 2004 Sep; 104(6):1679-87. PubMed ID: 15166036
[TBL] [Abstract][Full Text] [Related]
20. TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2.
Goetze S; Kintscher U; Kaneshiro K; Meehan WP; Collins A; Fleck E; Hsueh WA; Law RE
Atherosclerosis; 2001 Nov; 159(1):93-101. PubMed ID: 11689211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]